The headlines

This study investigates whether the mental health of those with facial differences is affected by the way they interpret the negative reactions of others.

A campaign has been launched by the Medicines and Healthcare products Regulatory Agency (MHRA) to raise awareness and offer advice about the risks associated with emollients and the potential to ignite and catch fire, once dried onto clothing.

Issue 51 of Skin 'n' Bones Connection is now available. A digital version is also available FREE to subscribing members.

Do you have 5 minutes to change psoriatic arthritis? Have your say and be part of the debate on psoriatic arthritis research.

Rheumatology research doctors from University College London Hospital have developed a survey for people with psoriatic arthritis...

An estimated 60 million people worldwide have the chronic skin condition, psoriasis, according to the latest results of the Global Psoriasis Atlas (GPA).

The availability of testing for COVID-19 has been widened to include groups beyond NHS frontline staff.

The Commission of Human Medicines (CHM)Expert Working Group on coronavirus (COVID-19) has concluded that there is currently insufficient evidence to establish a link between use of ibuprofen, or other non-steroidal anti-inflammatory drugs (NSAIDs), and susceptibility to contracting COVID-19 or the worsening of its symptoms.

New guidelines issued by NICE to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic. 

PsoProtect is an international registry for health care providers to report outcomes of COVID-19 in individuals with psoriasis.